Chin fillers are a non-surgical cosmetic treatment designed to improve chin shape, projection, and symmetry. Using hyaluronic acid or other safe dermal fillers, this quick procedure helps enhance the lower face, correct a recessed chin, and define the jawline—all without surgery. With expertly placed fillers, you can enjoy a sculpted, contoured look that complements your natural features.
.png)
A temporary and reversible option that enhances chin shape with natural results.
Longer-lasting support and volume while stimulating collagen production.
Gradually improves chin definition by encouraging natural collagen synthesis.
Chin fillers are suitable for:
Your journey begins with a personalized consultation. Our experts evaluate your facial structure and recommend the most suitable filler to achieve balanced, natural-looking results.
Before treatment, the skin is cleansed, and a topical numbing cream is applied. Patients receive pre-treatment guidance, including avoiding blood-thinning medications and alcohol, to ensure optimal results.
The procedure is minimally invasive and typically takes 15–30 minutes. Using fine needles or cannulas, our specialists inject the filler with precision, sculpting a harmonious and naturally defined chin.
Mild swelling or tenderness may occur but generally resolves within a few days. Patients are advised to avoid strenuous activities, excessive touching, or hot treatments for 24 hours. Aeon Clinic provides expert aftercare to support a smooth recovery.
Conditions like ankylosing spondylitis can cause parts of the spine to fuse, reducing flexibility.
EXOMIND helps regulate neural circuits related to reward and impulse control, reducing emotional eating, mindless snacking, and compulsive food behaviours. This therapy supports patients undergoing or post-GLP-1 weight loss treatment who are looking to manage long-term results through better self-regulation. It is a proven pathway for individuals seeking emotional eating therapy in Dubai.
For individuals who have not responded to medication or therapy, EXOMIND TMS in Dubai targets the brain’s mood centre to reduce emotional numbness, sadness, and hopelessness. Patients experience elevated happiness, optimism, and improved quality of life.
EXOMIND helps balance hyperactive brain circuits associated with persistent worry, panic attacks, and emotional instability. It is a powerful, non-pharmacological anxiety treatment in Dubai, ideal for those seeking long-term calm and clarity.
Chronic mental exhaustion and lack of motivation are often caused by disrupted brain connectivity. EXOMIND improves executive function and emotional regulation—making it ideal for executive burnout treatment in Dubai.
EXOMIND targets overactive brain loops involved in compulsive behaviours and unwanted thoughts. It provides relief for those struggling with OCD in Dubai, complementing existing behavioural therapies.
For those recovering from trauma, EXOMIND supports emotional regulation, reduces hypervigilance, and improves sleep. It offers a research-backed protocol for PTSD management in Dubai.
EXOMIND helps enhance focus, task completion, and emotional control without the need for stimulant medications. A valuable solution for adult patients seeking ADHD therapy in Dubai.
EXOMIND strengthens neural pathways responsible for memory, clarity, and speed of thought. Commonly used for brain fog treatment in Dubai, it is especially helpful for post-COVID fatigue, hormonal shifts, or high-stress lifestyles.
EXOMIND helps regulate brain wave patterns associated with restfulness. It reduces insomnia and improves energy levels, making it ideal for chronic fatigue and sleep optimisation in Dubai.
Emotional dysregulation often manifests through food cravings and impulsive eating. EXOMIND improves impulse control and self-regulation, helping individuals manage binge eating linked to depression in Dubai, especially post-GLP-1 therapy.
EXOMIND promotes long-term mental clarity, balance, and focus for individuals looking to optimise brain health proactively. It supports general mental wellness in Dubai for high performers, creatives, and those recovering from psychological strain.
Aesthetic Specialist & General Surgeon
Dr Mazen Al Samarrae is a highly skilled Aesthetic Specialist and General Surgeonwith over 20 years of experience. A member of The Royal College of Physicians and Surgeons of Glasgow (UK) since 2005, he has also completed training for the American Board of Regenerative Medicine Certificate, expanding his expertise in aesthetic and anti-ageing medicine.
With 11 years of experience in Reconstructive Plastic and Burn Surgeryat Mafraq Hospital/SSMC’s UAE National Burn Center, Dr Mazen has contributed extensively to burn treatment and reconstructive surgery, with several published worksin the field. His passion for aesthetic medicineled him to AEON Clinic, where he focuses on Botox, dermal fillers, burn and chronic wound management, skin lump excisions, skin rejuvenation treatments, and hair loss therapies.
Renowned for his precision, dedication, and patient-centred approach, Dr Mazen is a respected member of AEON Clinic’s distinguished medicalteam, committed to excellence in surgical and aesthetic care.
Clinical Director of Longevity of PureHealth & the Regional
Director of the British Society of Lifestyle Medicine in the Middle East
Board-certified UK-trained consultant in Family Medicine and lifestyle Medicine & is a Functional Medicine Practitioner
Dr Mishkat Shehata is a UK-trained, double board-certified Consultant in Family Medicine and Lifestyle Medicine, as well as a Functional Medicine Practitionerwith over 13 years of clinical expertise. She serves as the Clinical Director of Longevity at PureHealthand the Regional Director of the British Society of Lifestyle Medicine in the Middle East.
With a strong academic foundation, Dr Shehata holds a Master’s in Public Health (MPH)and a Master’s in Health Service Delivery and Disease Prevention, along with certifications in epigenetics, sports nutrition, and weight management. Her expertise extends beyond clinical practice, making her a thought leader in healthcare innovation and longevity medicine.
Founder and CEO of Bioscience Institute (RSM), Bioscience Clinic (Middle East) and Bioscience Genomics (Italy)
Giuseppe Mucci is the Founder and CEO of Bioscience Institute (RSM), Bioscience Clinic (Middle East), and Bioscience Genomics (Italy), leading innovations in genetics, regenerative medicine, and genomicssince 2005.
Under his leadership, Bioscience Grouphas established cutting-edge divisions, including a genetics division, a stem cell research and regenerative medicine division, and a genomics division. The genetics division, a spin-off of the University of Rome, operates laboratories at the San Raffaele Hospital in Milanand the University of Rome, focusing on fetal DNA sequencing for prenatal screeningand circulating cell-free DNA sequencing for cancer detection.
As the inventor of a patented algorithmthat identifies somatic mutations driving solid cancer development, Mucci has advanced precision medicine, enabling early cancer detection and prevention. His work in regenerative medicinehas led to clinical protocols for treating degenerative conditions, including tissue and organ ageingin skin, bones, cartilage, hair, ovaries, lungs, and salivary glands.
A former Professor of Bioeconomy at Lugano Universityand Advisory Board Member at the University of Rome Tor Vergata, he holds a degree in Medical Science (Physical Education) from Urbino University.
His contributions to healthcare innovationhave earned him multiple accolades, including Excellence and Innovation from Dubai Healthcare City, Excellence in Research & Development in Genomics (Rome University), the Italian Master Startup Award, and the Leonardo Startup Prizefrom the Italian Quality Committee.
Global Development Director for the American Board of Regenerative Medicine and the American Society of Regenerative Medicine
Dr Rozina Badal Munir is an accomplished physician, regenerative medicine specialist, and ultrasound diagnostics expert, serving as the Global Development Director for the American Board of Regenerative Medicine and the American Society of Regenerative Medicinesince 2020. She plays a key role in standardising education and promoting best practicesin regenerative medicine worldwide, fostering collaboration among experts from 25+ countries.
A Diplomate and Fellow of the American Board of Regenerative Medicine (DABRM, FABRM), Dr Munir holds multiple certifications, including vascular interpretation, echocardiography, musculoskeletal ultrasound, and emergency medicine point-of-care ultrasound (POCUS). She has extensive clinical experience as an Ultrasound Specialist and Instructor at Kaiser Permanente West Los Angeles Medical Centerand various medical institutions in Los Angeles and Orange County.
Her expertise includes pain management, orthopaedic ultrasound, and regenerative medicine applications, with training at Johns Hopkins University, Kaiser Permanente, and the Darrow Stem Cells Institute. She is also a Professor of Medical Ultrasound at the National University of Medical Sciences (USA/Canada)and POCUS Program Director at APPNA MERIT Academy, where she developed a comprehensive ultrasound training programme.
A renowned speaker, Dr Munir has presented at leading global conferences, including the World Pain & Regenerative Medicine Conference and the Stem Cells MENA Forum (UAE). She has contributed to Arab Health Imaging & Diagnostic magazinesand actively engages in volunteer medical initiatives.
With a strong commitment to education, clinical research, and technological advancements in regenerative medicine, Dr Munir continues to drive innovation in patient care and medical education worldwide.
Stem Cell Consultant
Diplomat in both the American Academy of Anti-aging Medicine and the American Board ofRegenerative Medicine
Medical Affairs Director at the AEON Clinic
Dr. Salman Naeem Gilani is a highly respected Stem Cell Consultant, leveraging his extensive expertise to shape the landscape of regenerative medicine. Having pursued a Fellowship in Stem Cell Therapy, Dr. Gilani stands as a trailblazer in the field, consistently exploring innovative approaches to healthcare.
His standing as a Diplomat in both the American Academy of Anti-aging Medicine and the American Board of Regenerative Medicine reflects not only his dedication but also the recognition of his contributions to advancing medical knowledge and practice.Dr. Gilani is committed to pushing the boundaries of medical science, contributing significantly to the evolution of stem cell therapy.
Dr. Gilani is an Affiliate of the American Board of Regenerative Medicine for UAE and Pakistan chapters and is responsible for training doctors in the field of Regenerative Medicine.
His commitment to excellence, coupled with a passion for cutting-edge medical solutions, positions him as a key figure in the realm of regenerative medicine. Dr. Gilani’s work extends beyond conventional boundaries, contributing significantly to the ongoing evolution of healthcare practices globally. "Regenerative Medicine in Neurodevelopmental disorders"
PhD, King's College London
MSC, UAEU, in the Genetic Basis of Familial Hypercholesterolemia
Member of International Stem Cells Research Association (ISCCR)
Member of International Society of Cell and Gene Therapy
Member of the International Cryobiology Society
Head of UAE Stem Cell Group
Lead Researcher with the Biotechnology Research Centre at Abu Dhabi Technology Innovation Institute
Dr Shaikha Al Mazrouei is a distinguished biotechnology researcherand speaker, specialising in genomics and regenerative medicine. She holds a PhD from King's College London, where she researched liver transplants using hepatocyte microbes, and an MSc from UAEU, focusing on the genetic basis of familial hypercholesterolemia.
As Head of the UAE Stem Cell Groupand Lead Researcher at the Biotechnology Research Centre, Abu Dhabi Technology Innovation Institute, Dr Al Mazrouei plays a key role in advancing stem cell research and biotechnology. She is an active member of the International Stem Cells Research Association (ISCCR), the International Society of Cell and Gene Therapy, and the International Cryobiology Society.
Her contributions include the Emirates Genome Project with G42, DNA fingerprinting for the UAE Armed Forces and Abu Dhabi Police, and research at Khalifa University. Committed to fostering scientific innovation in the UAE, she continues to shape the future of biotechnology and regenerative medicine.
Senior Scientist & Research Project Leader at Roche
Postdoctoral Researcher at Institute Curie
PhD in Chromatin Biology and Epigenetics
Dr Tomasz Chelmicki is an accomplished scientistwith extensive expertise in genomics, epigenetics, and stem cell biology. As a Senior Scientist and Research Project Leader at Rochesince April 2021, he specialises in high-throughput CRISPR screening and disease modeling.
Previously, he served as a Postdoctoral Researcher at Institut Curie, where he focused on functional genomics and RNA metabolism related to endogenous retroviruses. As an EMBO Long-Term Postdoctoral Fellow, he conducted groundbreaking research on transposon regulation determinants. His work at the Max Planck Institutefurther strengthened his expertise in chromatin biology and transcription regulation.
Dr Chelmicki holds a PhD in Chromatin Biology and Epigenetics from the Max Planck Societyand an MS in Biology and Biochemistry from Jagiellonian University. His research continues to drive advancements in molecular biology and disease therapeutics
Chairman of ProtoClinic,
President of GRA MENA,
American Board Certified in Regenerative Medicine
MBBS and MSc in Aesthetic Medicine (Plastic Surgery Dept.)
International Fellowship in Dermatology (Harvard University)
Dr Wissam Adada is an internationally recognised leader in Regenerative Medicine and Stem Cell Therapy, pioneering cutting-edge treatmentsthat integrate advanced science with personalised patient care. As Chairman of ProtoClinic, he leads a multidisciplinary teamspecialising in Plastic Surgery, Dermatology, Aesthetics, Functional Medicine, and Regenerative Medicine.
Board-certified by the American Board of Regenerative Medicine, Dr Adada holds an MBBS and MSc in Aesthetic Medicine (Plastic Surgery Department), alongsideprestigious fellowships, including:
- International Fellowship in Dermatology (Harvard University)
- Fellowship in Hair Transplant Surgery
- Fellowship in Stem Cell & Regenerative Medicine
As President of the Global Regenerative Academy (GRA) MENA and a Scientific Board Member of the Global Regenerative Academy, Dr Adada plays a pivotal role in advancing regenerative medicine globally, driving innovation, education, and collaborationin this evolving field.
Renowned for transformative hair loss treatments, he has redefined biohacking and stem cell-based therapies, applying regenerative techniques to aesthetic medicine, dermatologic surgery, and laser technologies. His expertise enables revolutionary skin rejuvenation, tissue repair, and hair restoration solutions.
Fluent in English, Italian, and Arabic, Dr Adada provides comprehensive, patient-centred care, ensuring life-changing resultsfor a diverse global patient base. His work exemplifies the future of medicine—where regeneration meets innovation for unparalleled patient transformation.
Translational Neuroscientist
Scientist at UCLA and Roche
CEO of P7Swiss
Dr Zeynab (Mitra) Nayernia is a translational neuroscientist with over 12 years of experience in cellular and molecular pathways of neurological disorders. Her expertise spans gene regulation, neuronal morphogenesis, and intercellular communication, bridging fundamental research with clinical applications.
At UCLA and Roche (pRED & IHB), she utilised advanced stem cell technologies, microfluidics, and gene editing to model diseases and evaluate therapies for neurodevelopmental disorders and Alzheimer’s disease.
As CEO of P7Swiss, she focuses on personalised biological therapeutics, driving innovation in translational research. She holds a PhD in Science from the University of Geneva and an MSc in Medical Genetics from the University of Newcastle.
Distinguished Professor, Departments of Biochemistry and Physiology and Programme Director,
Healthy Longevity Translational Research Programme at Yong Loo Lin School of Medicine, National University of Singapore
Director at Centre for Healthy Longevity, National University Health System, Singapore
Professor Brian Kennedy is a Distinguished Professorat the Yong Loo Lin School of Medicine, National University of Singapore (NUS), where he leads the Healthy Longevity Translational Research Programmeand the Bia-Echo Asia Centre for Reproductive Longevity and Equality. He also serves as Director of the Centre for Healthy Longevity at the National University Health System, Singapore.
Globally recognised expert in ageing research, Prof. Kennedy has been instrumental in uncovering the roles of Sirtuins and the mTOR pathway in biological ageing and lifespan extension. His work focuses on ageing mechanisms, healthspan interventions, and biomarker developmentto advance longevity science.
As a leading figure in healthy ageing research, Prof. Kennedy continues to shape the future of translational medicine, developing innovative strategies to enhance lifespan and well-being.
Founder and CEO, Barzilai Longevity Consulting (Healthspan Coaching LLC)
Faculty member and Trustee at the Geneva College of Longevity Science
Diplomat of the American Board of Lifestyle Medicine
Dr David Barzilai, MD, PhD, MBA, MS, DipABLM is a globally recognised longevity medicine physician, consultant, and thought leader, dedicated to optimising healthspan through evidence-based strategies. As Founder and CEO of Barzilai Longevity Consulting (Healthspan Coaching LLC), he specialises in precision longevity science, guiding individuals and organisations in implementing cutting-edge advancements to enhance vitality and extend healthspan.
An inaugural faculty member and Trustee at the Geneva Collegeof Longevity Science, Dr Barzilai leverages his PhD in Health Services Researchto drive personalised medicine innovations. As a Diplomate of the American Board of Lifestyle Medicine, he leads initiatives in nutrition, physical activity, sleep, stress management, and comprehensive health optimisation.
Through agingdoc.com, he partners with clients to develop individualised longevity plans, integrating the latest breakthroughs in precision medicine. Known as 'Agingdoc' on X (formerly Twitter), he has cultivated a global network of academics, scientists, and scholars, actively sharing insights and fostering collaboration in aging and longevity medicine.
A respected international speaker, Dr Barzilai frequently delivers keynote addresses at leading scientific and clinical conferences. His expert guidance and strategic consultancymake him a key figure in advancing healthspan science, longevity research, and personalised healthcare solutions.
Chairman and Director of the Institute of Neurophysiology at the Universität Zu Köln
Founding President of the German Society for Stem Cell Research
Professor Jürgen Hescheler is a pioneering neurophysiologist and expert in stem cell research, serving as Chairman and Director of the Institute of Neurophysiology at the Universität zu Köln. He is also the Founding President of the German Society for Stem Cell Research.
With a medical degree from the Universität des Saarlandes, Prof. Hescheler completed his doctoral thesis on Ca²⁺-channel blockers (summa cum laude) and habilitated in Physiology. His research focuses on cellular signalling, cardiac myocyte regulation, and neurophysiology, contributing to groundbreaking advancements in regenerative medicine.
A visiting professor at leading global institutions, he has coordinated European research consortia such as FunGenES and ESNATS. His work has earned numerous accolades, including the Claude Bernard Prize, Copp Prize, and Dorothy Hegarty Award, along with an Honorary Doctorate from Tongji Medical Faculty, China.
With 733 peer-reviewed publications and an H-index of 80, Prof. Hescheler actively reviews for Nature, Science, and Cell and serves on editorial boards of major scientific journals. His contributions continue to shape the future of stem cell research and regenerative medicine.
Professor Molecular Medicine
Member of the Biotechnology and regenerative medicine group in Medical Biology Research Center, Kermanshah, Iran.
Professor Kamran Mansouri is a Professor of Molecular Medicineand a member of the Biotechnology and Regenerative Medicine Group at the Medical Biology Research Center in Kermanshah, Iran.
He earned his Ph.D. in Molecular Medicine from Tehran University of Medical Sciences, where his research focused on the role of TSGA10 in angiogenesisand tumour metastasis. Following his doctoral studies, he joined the Medical Biology Research Center, contributing to biotechnology and regenerative medicine advancements.
Prof. Mansouri's expertise lies in molecular pathways of disease, tumour biology, and regenerative therapies, making him a key figure in biomedical research and translational medicine.
Founder and Consultant, Ming Medical in Malaysia Immunotherapy & Regenerative Medicine
Professor Sean Ng is the founder of MING Medical, a leading research and consulting organisation in Immunotherapy and Regenerative Medicine. With over a decade of expertise in cell-based therapies, bioreactors, and media optimisation, he has pioneered advancements in longevity, anti-ageing, cancer therapy, and organ regeneration.
Under his leadership, MING has developed Class-1 and Class-2 Cellular Platforms, including:
- Allogeneic Mesenchymal Stem Cells (MSCs)–Orthopaedics, neural regeneration, autism, cerebral palsy.
- Cord Blood Haematopoietic Stem Cells–Bone marrow regeneration.
- Multipotent Exosomes–Cardiomyopathy, nephropathy, stroke, dementia
- Pluripotent Exosomes–Fertility support, spinal cord reattachment.
- Telomere Exosomes–Type-2 diabetes, telomere lengthening, metabolism boost
- Allogeneic Natural Killer Cells–Solid and blood cancers, viral infections (Hep B/C)
Through collaborations with medical institutions across Malaysia, East Asia, and the Middle East, he continues to drive evidence-based innovationsand provides Clinical Protocol Guidelines (CPG)for clinicians worldwide.
Founder of European Prevention Center (EPC)
Internist, Cardiologist, and Sports Medicine Specialist
Renowned for his contributions to Preventive Cardiology
Professor Uwe Nixdorff is a leading internist, cardiologist, and sports medicine specialist, renowned for his contributions to preventive cardiology. As the Founder of the European Prevention Center (EPC), he has pioneered clinical algorithms for early disease detection and prevention, integrating advanced imaging techniques into cardiovascular diagnostics and preventive medicine.
With a background in echocardiographic research, Prof. Nixdorff played a key role in developing stress echocardiography and tissue Doppler echocardiography in the 1990s, forming the basis of his post-doctoral thesis at Johannes Gutenberg University, Mainz. As a senior physician at Friedrich-Alexander-University Erlangen-Nuremberg (FAU), he expanded his research to magnetic resonance and computed tomography, strengthening his focus on chronic coronary syndrome and myocardial infarction studies.
Driven by a passion for disease prevention, he established EPC, applying cutting-edge diagnostic and therapeutic approaches that extend beyond traditional cardiology to optimise patient health outcomes. His work continues to shape the future of preventive medicine and cardiovascular health.
Your journey begins with a personalized consultation. Our experts evaluate your facial structure and recommend the most suitable filler to achieve balanced, natural-looking results.
Before treatment, the skin is cleansed, and a topical numbing cream is applied. Patients receive pre-treatment guidance, including avoiding blood-thinning medications and alcohol, to ensure optimal results.
The procedure is minimally invasive and typically takes 15–30 minutes. Using fine needles or cannulas, our specialists inject the filler with precision, sculpting a harmonious and naturally defined chin.
Mild swelling or tenderness may occur but generally resolves within a few days. Patients are advised to avoid strenuous activities, excessive touching, or hot treatments for 24 hours. Aeon Clinic provides expert aftercare to support a smooth recovery.
Transform your profile with Chin Fillers in Dubai at Aeon Clinic. Our
team of specialists ensures every procedure is tailored to your features
for subtle, elegant results.
Chin fillers are non-surgical dermal injections used to enhance the shape, projection, and symmetry of the chin. They help create a defined jawline and balanced facial profile.
The results typically last 6–18 months, depending on the type of filler used, your metabolism, and lifestyle factors.
Most patients experience minimal discomfort. A topical numbing cream is applied before treatment to ensure a comfortable experience.
Yes. When performed by trained specialists, chin fillers are safe, minimally invasive, and carry a low risk of complications.
Results are usually visible immediately after treatment, with final results appearing once any swelling subsides (typically within a few days).
Absolutely. Chin fillers are ideal for enhancing a weak or receding chin, improving facial balance, and defining the jawline.
Recovery is quick. Most patients can resume daily activities immediately, although mild swelling or tenderness may occur for 1–3 days.
Yes. Hyaluronic acid fillers can be dissolved using a special enzyme if needed, allowing for adjustments or reversals.
Candidates include anyone seeking a more defined chin, improved jawline, correction of asymmetry, or a subtle, non-surgical enhancement of the lower face.
Aeon Clinic offers a holistic approach with a team of top aesthetic surgeons to ensure safe, natural-looking, and long-lasting results tailored to your facial structure.
Notifications
Copyright © AEON. All Rights Reserved. MOH: BTQWCN33-210125
+971 4 518 5777
E-Gift Vouchers